Fundamentals Hub
HSCS HeartSciences Inc.
HSCS financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 5 annual and 0 of 21 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
<br>Emerging growth company
Entity Type
Operating
Public Float
$10.40M (Oct 2025)
Industry (SIC)
6199 Finance Services
Incorporated
TX
Fiscal Year End
April (0430)
Phone
682-237-7781
EIN
261344466
Headquarters
SOUTHLAKE, TX, 76092
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names:
Heart Test Laboratories, Inc. (2009–2024)
▼ Key Metrics (TTM)
As of Jul 31, 2026Financials
Revenue
$4.52K
Net Income
$-10.26M
Total Assets
$3.74M
Total Equity
$-2.03M
Total Debt
-
Free Cash Flow
-
Ratios
Gross Margin
60.9%
Operating Margin
-209733.1%
Net Margin
-227024.2%
Return on Equity
504.6%
Return on Assets
-274.5%
Current Ratio
0.14x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2026 📄 | FY2025 📄 | FY2024 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| Revenue | $4.32K | $4.35K | $18.60K |
| Cost of Revenue | $1.77K | $1.88K | $6.08K |
| Gross Profit | $2.55K | $2.47K | $12.52K |
| OPERATING EXPENSES | |||
| R&D Expense | $2.84M | $4.39M | $2.88M |
| SG&A Expense | $5.58M | $3.97M | $3.44M |
| Other Operating Expenses (derived) | $0 | $0 | $0 |
| Operating Income | $-8.41M | $-8.35M | $-6.31M |
| NON-OPERATING INCOME / EXPENSE | |||
| Interest Expense | - | - | $354.08K |
| Other Income/Expense | $24.03K | $87.80K | $-299.44K |
| Income Tax | $0 | $0 | - |
| Net Income | $-9.14M | $-8.77M | $-6.61M |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | - | $-9.34 | $-18.74 |
| Diluted Shares | - | 938.26K | 352.52K |
| EBITDA | $-8.39M | $-8.31M | $-6.28M |
| Depreciation & Amortization | $27.79K | $37.60K | $27.89K |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | - | $1.10M | $5.81M |
| Accounts Receivable | - | $4.35K | - |
| Inventory | - | $650.27K | $629.18K |
| Other Current Assets | - | $40.37K | $40.37K |
| Current Assets | - | $2.17M | $7.35M |
| PP&E (Net) | - | $63.55K | $97.99K |
| Intangible Assets | - | $1.62M | $1.59M |
| Noncurrent Assets | - | $2.05M | $2.15M |
| Total Assets | - | $4.22M | $9.50M |
| LIABILITIES | |||
| Accounts Payable | - | $318.66K | $448.18K |
| Other Current Liabilities | - | $29.93K | $34.15K |
| Current Liabilities | - | $3.70M | $1.75M |
| Noncurrent Liabilities | - | $314.53K | $434.05K |
| Total Liabilities | - | $4.02M | $2.19M |
| EQUITY | |||
| Common Stock | - | $1.12K | $677 |
| Additional Paid-in Capital | - | $76.33M | $74.68M |
| Retained Earnings | - | $-76.13M | $-67.36M |
| Total Equity | - | $205.17K | $7.32M |
| Total Liabilities & Equity | - | $4.22M | $9.50M |
| SUPPLEMENTAL | |||
| Shares Outstanding | - | 1.12M | 676.60K |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-7.43M | $-7.41M | $-6.07M |
| Capital Expenditures | $3.55K | $3.16K | $64.46K |
| Cash from Investing | $-44.45K | $-30.19K | $-125.27K |
| Cash from Financing | $8.03M | $2.73M | $10.34M |
| Free Cash Flow | $-7.43M | $-7.42M | $-6.13M |
| Beginning Cash (CFS) | $1.10M | $5.81M | $1.66M |
| Net Change in Cash | $558.72K | $-4.71M | $4.15M |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | $1.66M | $1.10M | $5.81M |
| Cash per BS | - | $1.10M | $5.81M |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $1.66M | $1.10M | $5.81M |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
What is HeartSciences Inc.'s annual revenue?
HeartSciences Inc. reported $4.52K in revenue for trailing twelve months (ending July 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.
Is HeartSciences Inc. profitable?
No. HeartSciences Inc. reported $-10.26M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.